Global Extremity Reconstruction
Global Extremity Reconstruction

Extremity Reconstruction Comprehensive Study by Type (Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow reconstruction, Hand and wrist reconstruction), Lower Extremity (Foot Fusion (Hind foot Fusion, Other fusion devices) Ankle reconstruction (Ankle Fusion, Ankle Replacement))), End User (Hospitals, Clinic, Others), Biomaterials (Metallic, Polymeric, Ceramic, Natural) Players and Region - Global Market Outlook to 2026

Extremity Reconstruction Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 207 Pages 225 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Extremity Reconstruction Market Scope
Owing to the increasing number of patients suffering from cancers, chronic diseases, and accident-related injuries that result in the removal of extremities, it is becoming increasingly important for developments in this field to take up greater investments from the healthcare industry. Extremity reconstruction may be necessary after trauma or cancer removal. The arms and legs are important areas of the body, and extremity wounds can greatly affect mobility and lifestyle. Upper-extremity reconstruction can improve function for people with catastrophic spinal cord or brain injuries who have limited function in their arms, wrists, and hands. The rising number of cases of abnormalities and injuries in the lower and upper extremities of the human body encourages the growth of the global market in the forecasted period. In addition, technological advancements in extremity reconstruction devices and advancement in healthcare infrastructure are anticipated to accelerate the development of the market in the near future.

The Extremity Reconstruction market study is segmented by Type (Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow reconstruction, Hand and wrist reconstruction) and Lower Extremity (Foot Fusion (Hind foot Fusion, Other fusion devices) Ankle reconstruction (Ankle Fusion, Ankle Replacement))) and major geographies with country level break-up.

Leading global players are focusing on strategic partnerships to improve their products and services. The top firms are in a competition that has their strong R&D backup for research studies and the further things which are required to get approval for new devices. Mergers and acquisitions are other options to change the market strategies and earn more reputation in the market. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Extremity Reconstruction market throughout the predicted period.

Zimmer Biomet (United States), Wright Medical Group N.V (Netherlands), CONMED Corporation (United States), Acumed, LLC (United States), Arthrex (United States), DePuy Synthes (United States), Stryker Corporation (United States), Smith & Nephew plc (United Kingdom) and Integra Lifesciences Holdings Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Skeletal Dynamics LLC. (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Extremity Reconstruction market by Type, Application and Region.

On the basis of geography, the market of Extremity Reconstruction has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
In April 2019, Acumed, a leading manufacturer of orthopaedic surgical solutions, is pleased to announce the acquisition of technology that will help the company provide a total elbow arthroplasty (TEA) solution to the market. Acumed Acquires New Elbow Arthroplasty Technology.
In May 2020, Integra LifeSciences Holding Corporation announced positive clinical and economic data on Integraź Bilayer Wound Matrix (IBWM) in complex lower extremity reconstruction.


Market Trend
  • Technological Innovations in the Field of Extremity Implants

Market Drivers
  • Increase in the Number of Joint Disorders such as Osteoarthritis and Rheumatoid Arthritis
  • Rising Geriatric Population

Opportunities
  • Increasing Awareness among Patients about the Benefits of Joint Reconstruction Implants
  • Advancements in the Healthcare Infrastructure in Developing Countries

Restraints
  • Hig Cost of Treatment

Challenges
  • Failures & Complications Associated with the Surgery


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Extremity Reconstruction Providers, Extremity Reconstruction Equipment Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

Frequently asked questions:
1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Extremity Reconstruction Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Report Objectives / Segmentation Covered
By Type
  • Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow reconstruction, Hand and wrist reconstruction)
  • Lower Extremity (Foot Fusion (Hind foot Fusion, Other fusion devices) Ankle reconstruction (Ankle Fusion, Ankle Replacement))
By End User
  • Hospitals
  • Clinic
  • Others

By Biomaterials
  • Metallic
  • Polymeric
  • Ceramic
  • Natural

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Number of Joint Disorders such as Osteoarthritis and Rheumatoid Arthritis
      • 3.2.2. Rising Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Failures & Complications Associated with the Surgery
    • 3.4. Market Trends
      • 3.4.1. Technological Innovations in the Field of Extremity Implants
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Extremity Reconstruction, by Type, End User, Biomaterials and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Extremity Reconstruction (Value)
      • 5.2.1. Global Extremity Reconstruction by: Type (Value)
        • 5.2.1.1. Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow reconstruction, Hand and wrist reconstruction)
        • 5.2.1.2. Lower Extremity (Foot Fusion (Hind foot Fusion, Other fusion devices) Ankle reconstruction (Ankle Fusion, Ankle Replacement))
      • 5.2.2. Global Extremity Reconstruction by: End User (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinic
        • 5.2.2.3. Others
      • 5.2.3. Global Extremity Reconstruction by: Biomaterials (Value)
        • 5.2.3.1. Metallic
        • 5.2.3.2. Polymeric
        • 5.2.3.3. Ceramic
        • 5.2.3.4. Natural
      • 5.2.4. Global Extremity Reconstruction Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Extremity Reconstruction (Price)
      • 5.3.1. Global Extremity Reconstruction by: Type (Price)
  • 6. Extremity Reconstruction: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zimmer Biomet (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Wright Medical Group N.V (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. CONMED Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Acumed, LLC (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Arthrex (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. DePuy Synthes (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Stryker Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Smith & Nephew plc (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Integra Lifesciences Holdings Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Extremity Reconstruction Sale, by Type, End User, Biomaterials and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Extremity Reconstruction (Value)
      • 7.2.1. Global Extremity Reconstruction by: Type (Value)
        • 7.2.1.1. Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow reconstruction, Hand and wrist reconstruction)
        • 7.2.1.2. Lower Extremity (Foot Fusion (Hind foot Fusion, Other fusion devices) Ankle reconstruction (Ankle Fusion, Ankle Replacement))
      • 7.2.2. Global Extremity Reconstruction by: End User (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinic
        • 7.2.2.3. Others
      • 7.2.3. Global Extremity Reconstruction by: Biomaterials (Value)
        • 7.2.3.1. Metallic
        • 7.2.3.2. Polymeric
        • 7.2.3.3. Ceramic
        • 7.2.3.4. Natural
      • 7.2.4. Global Extremity Reconstruction Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Extremity Reconstruction (Price)
      • 7.3.1. Global Extremity Reconstruction by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Extremity Reconstruction: by Type(USD Million)
  • Table 2. Extremity Reconstruction Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow reconstruction, Hand and wrist reconstruction) , by Region USD Million (2015-2020)
  • Table 3. Extremity Reconstruction Lower Extremity (Foot Fusion (Hind foot Fusion, Other fusion devices) Ankle reconstruction (Ankle Fusion, Ankle Replacement)) , by Region USD Million (2015-2020)
  • Table 4. Extremity Reconstruction: by End User(USD Million)
  • Table 5. Extremity Reconstruction Hospitals , by Region USD Million (2015-2020)
  • Table 6. Extremity Reconstruction Clinic , by Region USD Million (2015-2020)
  • Table 7. Extremity Reconstruction Others , by Region USD Million (2015-2020)
  • Table 8. Extremity Reconstruction: by Biomaterials(USD Million)
  • Table 9. Extremity Reconstruction Metallic , by Region USD Million (2015-2020)
  • Table 10. Extremity Reconstruction Polymeric , by Region USD Million (2015-2020)
  • Table 11. Extremity Reconstruction Ceramic , by Region USD Million (2015-2020)
  • Table 12. Extremity Reconstruction Natural , by Region USD Million (2015-2020)
  • Table 13. South America Extremity Reconstruction, by Country USD Million (2015-2020)
  • Table 14. South America Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 15. South America Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 16. South America Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 17. Brazil Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 18. Brazil Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 19. Brazil Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 20. Argentina Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 21. Argentina Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 22. Argentina Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 23. Rest of South America Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 24. Rest of South America Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 25. Rest of South America Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 26. Asia Pacific Extremity Reconstruction, by Country USD Million (2015-2020)
  • Table 27. Asia Pacific Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 28. Asia Pacific Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 29. Asia Pacific Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 30. China Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 31. China Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 32. China Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 33. Japan Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 34. Japan Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 35. Japan Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 36. India Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 37. India Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 38. India Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 39. South Korea Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 40. South Korea Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 41. South Korea Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 42. Taiwan Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 43. Taiwan Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 44. Taiwan Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 45. Australia Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 46. Australia Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 47. Australia Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 51. Europe Extremity Reconstruction, by Country USD Million (2015-2020)
  • Table 52. Europe Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 53. Europe Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 54. Europe Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 55. Germany Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 56. Germany Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 57. Germany Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 58. France Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 59. France Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 60. France Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 61. Italy Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 62. Italy Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 63. Italy Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 64. United Kingdom Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 65. United Kingdom Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 66. United Kingdom Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 67. Netherlands Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 68. Netherlands Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 69. Netherlands Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 70. Rest of Europe Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 71. Rest of Europe Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 72. Rest of Europe Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 73. MEA Extremity Reconstruction, by Country USD Million (2015-2020)
  • Table 74. MEA Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 75. MEA Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 76. MEA Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 77. Middle East Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 78. Middle East Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 79. Middle East Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 80. Africa Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 81. Africa Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 82. Africa Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 83. North America Extremity Reconstruction, by Country USD Million (2015-2020)
  • Table 84. North America Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 85. North America Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 86. North America Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 87. United States Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 88. United States Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 89. United States Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 90. Canada Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 91. Canada Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 92. Canada Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 93. Mexico Extremity Reconstruction, by Type USD Million (2015-2020)
  • Table 94. Mexico Extremity Reconstruction, by End User USD Million (2015-2020)
  • Table 95. Mexico Extremity Reconstruction, by Biomaterials USD Million (2015-2020)
  • Table 96. Extremity Reconstruction: by Type(USD/Units)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Extremity Reconstruction: by Type(USD Million)
  • Table 107. Extremity Reconstruction Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow reconstruction, Hand and wrist reconstruction) , by Region USD Million (2021-2026)
  • Table 108. Extremity Reconstruction Lower Extremity (Foot Fusion (Hind foot Fusion, Other fusion devices) Ankle reconstruction (Ankle Fusion, Ankle Replacement)) , by Region USD Million (2021-2026)
  • Table 109. Extremity Reconstruction: by End User(USD Million)
  • Table 110. Extremity Reconstruction Hospitals , by Region USD Million (2021-2026)
  • Table 111. Extremity Reconstruction Clinic , by Region USD Million (2021-2026)
  • Table 112. Extremity Reconstruction Others , by Region USD Million (2021-2026)
  • Table 113. Extremity Reconstruction: by Biomaterials(USD Million)
  • Table 114. Extremity Reconstruction Metallic , by Region USD Million (2021-2026)
  • Table 115. Extremity Reconstruction Polymeric , by Region USD Million (2021-2026)
  • Table 116. Extremity Reconstruction Ceramic , by Region USD Million (2021-2026)
  • Table 117. Extremity Reconstruction Natural , by Region USD Million (2021-2026)
  • Table 118. South America Extremity Reconstruction, by Country USD Million (2021-2026)
  • Table 119. South America Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 120. South America Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 121. South America Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 122. Brazil Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 123. Brazil Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 124. Brazil Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 125. Argentina Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 126. Argentina Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 127. Argentina Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 128. Rest of South America Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 129. Rest of South America Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 130. Rest of South America Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 131. Asia Pacific Extremity Reconstruction, by Country USD Million (2021-2026)
  • Table 132. Asia Pacific Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 133. Asia Pacific Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 134. Asia Pacific Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 135. China Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 136. China Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 137. China Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 138. Japan Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 139. Japan Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 140. Japan Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 141. India Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 142. India Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 143. India Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 144. South Korea Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 145. South Korea Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 146. South Korea Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 147. Taiwan Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 148. Taiwan Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 149. Taiwan Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 150. Australia Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 151. Australia Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 152. Australia Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 153. Rest of Asia-Pacific Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 154. Rest of Asia-Pacific Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 155. Rest of Asia-Pacific Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 156. Europe Extremity Reconstruction, by Country USD Million (2021-2026)
  • Table 157. Europe Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 158. Europe Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 159. Europe Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 160. Germany Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 161. Germany Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 162. Germany Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 163. France Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 164. France Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 165. France Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 166. Italy Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 167. Italy Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 168. Italy Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 169. United Kingdom Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 170. United Kingdom Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 171. United Kingdom Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 172. Netherlands Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 173. Netherlands Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 174. Netherlands Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 175. Rest of Europe Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 176. Rest of Europe Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 177. Rest of Europe Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 178. MEA Extremity Reconstruction, by Country USD Million (2021-2026)
  • Table 179. MEA Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 180. MEA Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 181. MEA Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 182. Middle East Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 183. Middle East Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 184. Middle East Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 185. Africa Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 186. Africa Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 187. Africa Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 188. North America Extremity Reconstruction, by Country USD Million (2021-2026)
  • Table 189. North America Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 190. North America Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 191. North America Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 192. United States Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 193. United States Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 194. United States Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 195. Canada Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 196. Canada Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 197. Canada Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 198. Mexico Extremity Reconstruction, by Type USD Million (2021-2026)
  • Table 199. Mexico Extremity Reconstruction, by End User USD Million (2021-2026)
  • Table 200. Mexico Extremity Reconstruction, by Biomaterials USD Million (2021-2026)
  • Table 201. Extremity Reconstruction: by Type(USD/Units)
  • Table 202. Research Programs/Design for This Report
  • Table 203. Key Data Information from Secondary Sources
  • Table 204. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Extremity Reconstruction: by Type USD Million (2015-2020)
  • Figure 5. Global Extremity Reconstruction: by End User USD Million (2015-2020)
  • Figure 6. Global Extremity Reconstruction: by Biomaterials USD Million (2015-2020)
  • Figure 7. South America Extremity Reconstruction Share (%), by Country
  • Figure 8. Asia Pacific Extremity Reconstruction Share (%), by Country
  • Figure 9. Europe Extremity Reconstruction Share (%), by Country
  • Figure 10. MEA Extremity Reconstruction Share (%), by Country
  • Figure 11. North America Extremity Reconstruction Share (%), by Country
  • Figure 12. Global Extremity Reconstruction: by Type USD/Units (2015-2020)
  • Figure 13. Global Extremity Reconstruction share by Players 2020 (%)
  • Figure 14. Global Extremity Reconstruction share by Players (Top 3) 2020(%)
  • Figure 15. Global Extremity Reconstruction share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Zimmer Biomet (United States) Revenue, Net Income and Gross profit
  • Figure 18. Zimmer Biomet (United States) Revenue: by Geography 2020
  • Figure 19. Wright Medical Group N.V (Netherlands) Revenue, Net Income and Gross profit
  • Figure 20. Wright Medical Group N.V (Netherlands) Revenue: by Geography 2020
  • Figure 21. CONMED Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. CONMED Corporation (United States) Revenue: by Geography 2020
  • Figure 23. Acumed, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 24. Acumed, LLC (United States) Revenue: by Geography 2020
  • Figure 25. Arthrex (United States) Revenue, Net Income and Gross profit
  • Figure 26. Arthrex (United States) Revenue: by Geography 2020
  • Figure 27. DePuy Synthes (United States) Revenue, Net Income and Gross profit
  • Figure 28. DePuy Synthes (United States) Revenue: by Geography 2020
  • Figure 29. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Stryker Corporation (United States) Revenue: by Geography 2020
  • Figure 31. Smith & Nephew plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Smith & Nephew plc (United Kingdom) Revenue: by Geography 2020
  • Figure 33. Integra Lifesciences Holdings Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 34. Integra Lifesciences Holdings Corporation (United States) Revenue: by Geography 2020
  • Figure 35. Global Extremity Reconstruction: by Type USD Million (2021-2026)
  • Figure 36. Global Extremity Reconstruction: by End User USD Million (2021-2026)
  • Figure 37. Global Extremity Reconstruction: by Biomaterials USD Million (2021-2026)
  • Figure 38. South America Extremity Reconstruction Share (%), by Country
  • Figure 39. Asia Pacific Extremity Reconstruction Share (%), by Country
  • Figure 40. Europe Extremity Reconstruction Share (%), by Country
  • Figure 41. MEA Extremity Reconstruction Share (%), by Country
  • Figure 42. North America Extremity Reconstruction Share (%), by Country
  • Figure 43. Global Extremity Reconstruction: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Zimmer Biomet (United States)
  • Wright Medical Group N.V (Netherlands)
  • CONMED Corporation (United States)
  • Acumed, LLC (United States)
  • Arthrex (United States)
  • DePuy Synthes (United States)
  • Stryker Corporation (United States)
  • Smith & Nephew plc (United Kingdom)
  • Integra Lifesciences Holdings Corporation (United States)
Additional players considered in the study are as follows:
Skeletal Dynamics LLC. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation